The indolent extranodal lymphomas: What is the role of radiation therapy?

Published: June 12, 2009
Abstract Views: 183
PDF: 700
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The indolent lymphomas include follicular lymphoma (grade 1-2), marginal zone lymphoma, mycosis fungoides, primary cutaneous follicle center lymphoma, and solitary plasmacytoma. Although the follicular lymphomas rarely present with extranodal involvement only, the other indolent lymphomas occur frequently or exclusively with extranodal localizations. Radiation therapy plays a meaningful role in the management of all of these diseases. For patients who present with stage I-IIE disease, that treatment may be with curative intent and expectation. But even patients with stage IIIE-IV disease may achieve meaningful palliation with radiation therapy. This review will consider the role of radiation therapy in the management of extranodal lymphoma in the overall context of treatments available for these diseases.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Hoppe, R. (2009). The indolent extranodal lymphomas: What is the role of radiation therapy?. Hematology Meeting Reports (formerly Haematologica Reports), 3(3). https://doi.org/10.4081/hmr.v3i3.555